Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells.

Lash LL, Wallar BJ, Turner JD, Vroegop SM, Kilkuskie RE, Kitchen-Goosen SM, Xu HE, Alberts AS.

Cancer Res. 2013 Nov 15;73(22):6793-803. doi: 10.1158/0008-5472.CAN-13-1593.

2.

Pharmacokinetic properties, induction of interferon, and efficacy of selected 5-halo-6-phenyl pyrimidinones, bropirimine analogues, in a model of severe experimental autoimmune encephalomyelitis.

Vroegop SM, Chapman DL, Decker DE, Galinet LA, Brideau RJ, Ready KA, Dunn CJ, Buxser SE.

Int J Immunopharmacol. 1999 Oct;21(10):647-62.

PMID:
12609460
3.

Pharmacology of the biological response modifier bropirimine (PNU-54461) on experimental autoimmune encephalomyelitis (EAE) in mice.

Vroegop SM, Chapman DL, Galinet LA, Decker DE, Ready KA, Brideau RJ, Dunn CJ, Buxser SE.

Int J Immunopharmacol. 1999 Jun;21(6):391-409.

PMID:
10405874
4.

Inhibition of oxidative insult in cultured cells by a novel 6-chromanol-containing antioxidant.

Decker DE, Vroegop SM, Buxser SE.

Biochem Pharmacol. 1995 Sep 28;50(7):1063-70.

PMID:
7575662
5.

Kinetics and thermodynamics of emulsion delivery of lipophilic antioxidants to cells in culture.

Decker DE, Vroegop SM, Goodman TG, Peterson T, Buxser SE.

Chem Phys Lipids. 1995 May 22;76(1):7-25.

PMID:
7788801
6.

Localization of damage induced by reactive oxygen species in cultured cells.

Vroegop SM, Decker DE, Buxser SE.

Free Radic Biol Med. 1995 Feb;18(2):141-51.

PMID:
7538090
8.

Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.

Nanduri J, Vroegop SM, Buxser SE, Neet KE.

J Neurosci Res. 1994 Mar 1;37(4):433-44.

PMID:
7517456
10.

Supplemental Content

Loading ...
Support Center